These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9152545

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
    Hirano T, Tomiyoshi K, Zhang YJ, Ishida T, Inoue T, Endo K.
    Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
    [Abstract] [Full Text] [Related]

  • 5. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U, Muratori F, Di Sacco G, Banfi F, Libroia A.
    Henry Ford Hosp Med J; 1989 Jan; 37(3-4):175-7. PubMed ID: 2576958
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. False-positive Tc-99m pentavalent DMSA uptake in the imaging of medullary carcinoma of the thyroid.
    Lette J, Monier D, Ledoux R, Levasseur A.
    Clin Nucl Med; 1991 Feb; 16(2):136-7. PubMed ID: 1848495
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid.
    Lebouthillier G, Morais J, Picard M, Picard D, Chartrand R, D'Amour P.
    Clin Nucl Med; 1993 Aug; 18(8):657-61. PubMed ID: 8403695
    [Abstract] [Full Text] [Related]

  • 12. 111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma.
    Berná L, Cabezas R, Mora J, Torres G, Estorch M, Carrió I.
    J Endocrinol; 1995 Feb; 144(2):339-45. PubMed ID: 7706986
    [Abstract] [Full Text] [Related]

  • 13. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
    Yen TC, King KL, Yang AH, Liu RS, Yeh SH.
    J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
    Becker W, Börner W, Reiners C.
    Horm Metab Res Suppl; 1989 Jan; 21():38-42. PubMed ID: 2553574
    [Abstract] [Full Text] [Related]

  • 16. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG, Farahati J, Bier D, Knust EJ, Reiners C.
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [Abstract] [Full Text] [Related]

  • 17. Technetium 99m pentavalent dimercaptosuccinic acid and thallium 201 in detecting recurrent medullary carcinoma of the thyroid.
    Bigsby RJ, Lepp EK, Litwin DE, Wilkinson AA, Matte GG.
    Can J Surg; 1992 Aug; 35(4):388-92. PubMed ID: 1323381
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA, Udelsman R, Soper ND, Shepstone BJ, Dudley NE.
    Clin Nucl Med; 1991 Apr; 16(4):259-62. PubMed ID: 1646098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.